​The magnitude of GBV incidence in Papua New Guinea is considered by some to be of epidemic proportions. The social, emotional and physical costs of GBV are widely recognised, as are national-level economic costs. But the impact at individual firm level is less well understood. This toolkit seeks to provide NGOs, academia or businesses with the means to assess the financial implications of GBV in the private sector.